Exclusive Online Content
Treatment Market for Irritable Bowel Syndrome Could Hit $1.5 Billion
The global therapeutics market for Irritable Bowel Syndrome (IBS) is set to rise in value from $589.6 million in 2013 to $1.5 billion by 2023,…
Unilife Enters Definitive Global Strategic Agreement With AbbVie
On January 15, 2015, Unilife Corporation (Unilife) entered into a definitive global strategic agreement with AbbVie Inc. (AbbVie) for the customization and supply of its…
Orphan Drug Prices Facing Increased Scrutiny Following Historic Year for Approvals
With the US Food and Drug Administration (FDA) approving an all-time record number of orphan drugs during 2014, the pricing of these treatments is set…
FREE WEBINAR - Analysts Predict a Big Year for Healthcare in 2015!
Find out what lies ahead as Frost & Sullivan’s healthcare futurists offer their bold predictions for the entire healthcare industry WHEN …
Denmark’s Pharmaceutical Market Value to Decline to $3 Billion by 2020
Denmark’s pharmaceutical market will decline in value from $3.5 billion in 2013 to $3 billion by 2020, with price-cap agreements and high tax rates on…
goBalto Announces Latest Release of goBalto Activate
goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, recently announced the release of its latest version of goBalto Activate, its flagship study startup…
Frost & Sullivan Releases Drug Launch Phase III Trial Watch List for Top Therapeutic Areas
The therapeutics market is buzzing with activity, as several promising therapies are progressing to Phase III clinical trials and many more are awaiting commercial launches.…
Global Cancer Vaccine Market to Reach $4.3 Billion in 2019
BCC Research recently announced in its new report, Cancer Vaccines: Technologies and Global Markets, the global market for cancer vaccines is expected to grow to…
Capsugel Acquires Ionic Liquids Technology
Morristown, N.J., and Melbourne, Australia – Capsugel and Monash University recently announced that Capsugel has acquired the intellectual property pertaining to proprietary Ionic Liquids Technology…
Record Number of Medicines for Rare Diseases Recommended for Approval in 2014
In 2014, the European Medicines Agency (EMA) recommended the highest number of orphan designated medicines for marketing authorisation in a year. Out of the 82…
Recently Discovered Super-Antibiotic Hailed as a Game-Changer
By: Anna Azvolinsky | January 7, 2015 | The Scientist Many of the most widely used antibiotics have come out of the dirt. Penicillin…
Roche to Enter the Genomic Informatics Market
Roche recently announced the acquisition of Bina Technologies, Inc. (Bina), a privately held company based in Redwood City, California, USA. Bina provides a big data…
FUJIFILM Completes Acquisition of Biotherapeutics Company
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, recently announced the completion of its acquisition of Kalon Biotherapeutics LLC, marking an important new chapter…
Hemispherx’s Ampligen Provides Anti-Tumor Activity Analogous to Emerging Immune Checkpoint Inhibitors
Philadelphia, PA, December 16, 2014: Hemispherx Biopharma, Inc. (NYSE MKT: HEB) (the “Company” or “Hemispherx”), recently announced further progress on developing Ampligen® (rintatolimod) as a potential…
Norwich Pharma Services Refines Business Strategy
Norwich, New York – December 16, 2014 – Norwich Pharma Services, a provider of contract manufacturing and clinical research services for the pharmaceutical industry, announced…
Top 30 Pharma Companies Spent $112 Billion on Research & Development in 2013
LONDON, UK (GlobalData), 16 December 2014 - The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013,…
Lightlake Therapeutics Announces Licensing Deal With Adapt Pharma Limited Subsidiary
LONDON, Dec. 16, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, recently…
Bioadhesives Poised to Replace Synthetic Solutions
The global bioadhesive industry is rapidly gaining prominence due to the evolution of biomaterials and the benefits of bioadhesives in a host of applications across…
Patent Cliff Means Pharmaceutical Companies Will Lose $65 Billion by 2019
Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent expiries of several leading drugs, according to research…
Stem Cell Therapies Gathering Momentum But Significant Challenges Remain
LONDON, UK (GlobalData), 9 December 2014 - With 104 programs in late-stage clinical development, the stem cell therapy space could reach the commercialization threshold by…
